Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and safety of Zicuiyin decoction on diabetic kidney disease: A multicenter, randomized controlled trial
Jia Liu, Lidong Gao, Bin Fu, et al.
Phytomedicine (2022) Vol. 100, pp. 154079-154079
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

The roles of gut microbiota and its metabolites in diabetic nephropathy
Hui Zhao, Cheng-E Yang, Tian Liu, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 27
Gut microbiota and its metabolites – molecular mechanisms and management strategies in diabetic kidney disease
Zi‐Hui Mao, Zhong‐Xiuzi Gao, Dongwei Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Advances in Traditional Chinese Medicine research in diabetic kidney disease treatment
Shiyi Shen, Huiyun Zhong, Xiaoshi Zhou, et al.
Pharmaceutical Biology (2024) Vol. 62, Iss. 1, pp. 222-232
Open Access | Times Cited: 15
Focusing on Formononetin: Recent Perspectives for its Neuroprotective Potentials
Jiao Tian, Xing-Qin Wang, Zhen Tian
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 36
Traditional Chinese Medicine in the Treatment of Chronic Kidney Diseases: Theories, Applications, and Mechanisms
Yunlai Wang, Ye Feng, Manman Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 35
Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota
Xiaqing Wu, Lei Zhao, Yanlong Zhao, et al.
Pharmaceutical Biology (2024) Vol. 62, Iss. 1, pp. 423-435
Open Access | Times Cited: 8
The mechanisms underlying Chinese medicines to treat inflammation in diabetic kidney disease
Leipengyun Deng, Chunru Shi, Run Li, et al.
Journal of Ethnopharmacology (2024) Vol. 333, pp. 118424-118424
Closed Access | Times Cited: 6
Huajuxiaoji Formula Alleviates Phenyl Sulfate‐Induced Diabetic Kidney Disease by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis
Zeng Zhang, Yueping Bi, Fengzhu Zhou, et al.
Journal of Diabetes Research (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 5
Therapeutic mechanism and clinical application of Chinese herbal medicine against diabetic kidney disease
Dan‐Qian Chen, Jun Wu, Ping Li
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
Effectiveness and safety of Tongxinluo capsule for diabetic kidney disease: A systematic review and meta-analysis
Maoying Wei, Yijia Jiang, Yi-Ting Tang, et al.
World Journal of Diabetes (2025) Vol. 16, Iss. 5
Closed Access
Intestinal flora and bile acid interactions impact the progression of diabetic kidney disease
Jia Xu, Nan Wang, Li Yang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Natural products from plants and microorganisms: Novel therapeutics for chronic kidney disease via gut microbiota regulation
Zheng Lin, Mingjing Luo, Haokui Zhou, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 9
Ferroptosis: a new strategy for Chinese herbal medicine treatment of diabetic nephropathy
Maoying Wei, Xingxing Liu, Zhijuan Tan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 9
Mechanistic Study of Schisandra chinensis Fruit Mixture Based on Network Pharmacology, Molecular Docking and Experimental Validation to Improve the Inflammatory Response of DKD Through AGEs/RAGE Signaling Pathway
Hongdian Li, Ao Dong, Na Li, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 613-632
Open Access | Times Cited: 8
Research progress of traditional Chinese medicine on the treatment of diarrhea by regulating intestinal microbiota and its metabolites based on renal-intestinal axis
Tong Zhou, Yifan Zhang, Zhaoyuan Li, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 2
The reporting quality of randomized controlled trials in Chinese herbal medicine (CHM) formulas for diabetes based on the consort statement and its extension for CHM formulas
Yan Liu, Chaoyue Hu, Kehua Zhou, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Chinese herbal medicine for the treatment of diabetic nephropathy: From clinical evidence to potential mechanisms
Xiaoxiao Gong, Linhai Cao, Hongxia Ni, et al.
Journal of Ethnopharmacology (2024) Vol. 330, pp. 118179-118179
Closed Access | Times Cited: 1
Exploring the molecular mechanisms for renoprotective effects of Huangkui capsule on diabetic nephropathy mice by comprehensive serum metabolomics analysis
Xiaotong Yan, Ping Li, Chang Liu, et al.
Journal of Ethnopharmacology (2024) Vol. 340, pp. 119223-119223
Closed Access | Times Cited: 1
Polysaccharide H-1-2 Ameliorates High Glucose-Induced Podocyte Dysfunction by Suppressing Epithelial-to-Mesenchymal Transition via Restoration of SIRT1 <i>in Vivo</i> and <i>in Vitro</i>
Minzhou Li, Zhong Wu, Wei Gao, et al.
The Tohoku Journal of Experimental Medicine (2023) Vol. 260, Iss. 1, pp. 35-45
Open Access | Times Cited: 3
The role of Chinese herbal medicine in the treatment of diabetic nephropathy by regulating endoplasmic reticulum stress
Maoying Wei, Xingxing Liu, Mingdi Li, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Novel therapeutic approaches in the management of chronic kidney disease: a narrative review
Panagiotis Theofilis, Aikaterini Vordoni, Rigas Kalaitzidis
Postgraduate Medicine (2023) Vol. 135, Iss. 6, pp. 543-550
Closed Access | Times Cited: 2
Targeting cellular senescence in senile osteoporosis: therapeutic potential of traditional Chinese medicine
Yingyi Zhang, Xinfeng Yu, Chengcong Zhou, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 2
Causal relationship between gut microbes and cardiovascular protein expression
Wenchuan Zhang, Shuwan Zhang, Feng Zhao, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 4
Efficacy and safety of traditional Chinese medicine decoction as an adjuvant treatment for diabetic nephropathy: a systematic review and meta-analysis of randomized controlled trials
Shuyu Zheng, XU Yun-xi, Ya Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Adverse events of herbal decoction: A systematic review and meta-analysis over past 10 years
Han‐Gyul Lee, Hye In Jeong, Chan‐Young Kwon, et al.
Complementary Therapies in Medicine (2024) Vol. 83, pp. 103057-103057
Open Access
Page 1 - Next Page

Scroll to top